2026 ICD-10-CM Diagnosis Code T38.6X2SPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela

ICD-10-CM Codes›S00–T88›T36-T50›T38

ICD-10-CM T38.6X2S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T38.6X2S is a billable ICD-10-CM diagnosis code for poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders; sequela; and Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T38.6X2S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela
Short Description
Poisn by antigonadtr/antiestr/antiandrg, NEC, slf-hrm, sqla
Parent Code
T38.6X2
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT38Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
This CodeT38.6X2SPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela

Present on Admission (POA)Billing

T38.6X2S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Estrogen antagonist overdose
  • Formestane overdose
  • Formestane poisoning
  • Intentional formestane overdose
  • Intentional formestane poisoning
  • Intentional poisoning caused by corticosteroid and/or corticosteroid derivative
  • Intentional tamoxifen overdose
  • Intentional tamoxifen poisoning
  • Tamoxifen overdose
  • Tamoxifen poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD034
Mental and substance use disorders; sequela
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Cyproterone

    an anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. it is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.

  • Cyproterone Acetate

    an agent with anti-androgen and progestational properties. it shows competitive binding with dihydrotestosterone at androgen receptor sites.

  • Danazol

    a synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. it possesses some androgenic properties. danazol has been used in the treatment of endometriosis and some benign breast disorders.

  • Flutamide

    an antiandrogen with about the same potency as cyproterone in rodent and canine species.

  • Mifepristone

    a progestational and glucocorticoid hormone antagonist. its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. as a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary cushing syndrome.

  • Nafoxidine

    an estrogen antagonist that has been used in the treatment of breast cancer.

  • Tamoxifen

    one of the selective estrogen receptor modulators with tissue-specific activities. tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium.

  • Toremifene

    a first generation selective estrogen receptor modulator (serm). like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect		Under­dosing
Antiandrogen NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
Antiestrogen NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
Antigonadotrophin NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
CyproteroneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
DanazolT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
FlutamideT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
MifepristoneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
NafoxidineT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
NilutamideT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
OrmeloxifeneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
TaleranolT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
TamoxifenT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
ToremifeneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6

Patient EducationClinical

Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T38.6X2S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E959 Late eff of self-injury
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T38.6X2SOverview

Is T38.6X2S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T38.6X2S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm itself has resolved, not the original event.

What MS-DRG does T38.6X2S group to?

When poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T38.6X2S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela on inpatient claims.

What is the ICD-9 equivalent of T38.6X2S?

Under the General Equivalence Mappings, poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E959 (late eff of self-injury). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.